Dehydroepiandrosterone sulphate in critical illness: effect of dopamine

OBJECTIVE As part of a study on the effect of dopamine therapy on pituitary dependent hormone secretion in critical illness, we documented the impact of this inotropic and vasoactive catecholamine on the serum concentrations of dehydroepiandrosterone sulphate (DHEAS). Concomitantly, serum levels of PRL and cortisol were determined.

[1]  J. Herbert.  The age of dehydroepiandrosterone , 1995, The Lancet.

[2]  F. Zegher,et al.  Dopamine and the sick euthyroid syndrome in critical illness , 1994, Clinical endocrinology.

[3]  E. Baulieu,et al.  Serum dehydroepiandrosterone sulfate levels as an individual marker. , 1994, The Journal of clinical endocrinology and metabolism.

[4]  F. Zegher,et al.  Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine , 1994, Clinical endocrinology.

[5]  G. Van den Berghe,et al.  Growth hormone secretion in critical illness: effect of dopamine. , 1994, The Journal of clinical endocrinology and metabolism.

[6]  B. Thompson,et al.  Renal-dose dopamine: a Siren song? , 1994, The Lancet.

[7]  S. Lightman,et al.  Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. , 1994, Immunology today.

[8]  A. Straughn,et al.  Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. , 1993, American Journal of Obstetrics and Gynecology.

[9]  J. Veldhuis,et al.  Dopamine Inhibits Growth Hormone and Prolactin Secretion in the Human Newborn , 1993, Pediatric Research.

[10]  R. Daynes,et al.  Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. , 1993, Journal of immunology.

[11]  R. Daynes,et al.  Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. , 1993, The Journal of infectious diseases.

[12]  R. Daynes,et al.  Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. , 1993, Archives of surgery.

[13]  E. Abraham,et al.  Haemorrhage‐induced alterations in function and cytokine production of T cells and T cell subpopulations , 1992, Clinical and experimental immunology.

[14]  G. Reisz,et al.  Effects of dopamine on T‐lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients , 1992, Critical care medicine.

[15]  C. Stokes,et al.  An early defect in primary and secondary T cell responses in asymptomatic cats during acute feline immunodeficiency virus (FIV) infection , 1992, Clinical and experimental immunology.

[16]  R. Daynes,et al.  The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  E. Bernton,et al.  Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. , 1991, Endocrinology.

[18]  R. Daynes,et al.  Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. , 1991, Clinical immunology and immunopathology.

[19]  J. Miell,et al.  Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin–like growth factor‐I , 1991, Clinical endocrinology.

[20]  R. Daynes,et al.  Adrenal androgen secretion and biologic effects. , 1991, Endocrinology and metabolism clinics of North America.

[21]  R. Daynes,et al.  Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. , 1991, Research in immunology.

[22]  J. Copeland,et al.  Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation. , 1990, The Annals of thoracic surgery.

[23]  D. McRitchie,et al.  Impaired antibody production in blunt trauma. Possible role for T cell dysfunction. , 1990, Archives of surgery.

[24]  E. Abraham,et al.  Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. , 1989, Journal of immunology.

[25]  L. Parker.  Adrenal Androgens in Clinical Medicine , 1989 .

[26]  D. Russell.  New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. , 1989, Trends in pharmacological sciences.

[27]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[28]  J. Holaday,et al.  Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. , 1988, Science.

[29]  C. Baxter,et al.  Effect of burn trauma on adrenal and testicular steroid hormone production. , 1987, The Journal of clinical endocrinology and metabolism.

[30]  D. Drucker,et al.  Adrenocortical dysfunction in acute medical illness , 1986, Critical care medicine.

[31]  G. Chrousos,et al.  The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects. , 1986 .

[32]  L. Matrisian,et al.  Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. , 1985, Journal of immunology.

[33]  K. Swedberg,et al.  Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. , 1985, The American journal of medicine.

[34]  H. Nawata,et al.  Prolactin has a direct effect on adrenal androgen secretion. , 1984, The Journal of clinical endocrinology and metabolism.

[35]  E. Levy,et al.  Changes in mitogen responsiveness lymphocyte subsets after traumatic injury: relation to development of sepsis. , 1984, Clinical immunology and immunopathology.

[36]  R. Lobo,et al.  Prolactin modulation of dehydroepiandrosterone sulfate secretion. , 1980, American journal of obstetrics and gynecology.

[37]  A. Pupi,et al.  PLASMA DEHYDROEPIANDROSTERONE SULPHATE IN HYPOTHYROID PREMENOPAUSAL WOMEN , 1980, Clinical endocrinology.

[38]  M. Sole,et al.  Plasma dopamine responses to standing and exercise in man. , 1979, Life sciences.

[39]  J. Meakins,et al.  Delayed Hypersensitivity: Indicator of Acquired Failure of Host Defenses in Sepsis and Trauma , 1977, Annals of surgery.

[40]  R. Rubens,et al.  Effect of prolactin on plasma DHEA (s) levels. , 1977, The Journal of clinical endocrinology and metabolism.

[41]  L. I. Goldberg,et al.  Dopamine--clinical uses of an endogenous catecholamine. , 1974, The New England journal of medicine.

[42]  P. Kelly,et al.  Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. , 1974, Endocrinology.